Evidence map›Paper›PMID 40528680›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Synthesis of Chirally Chimeric Protein Nanoparticle Vaccines via Mirror-Image Spy Chemistry.

Songzi Kou, Chenbo Sun, Weitao Chen, Hanyu Gao, Fei Sun

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Songzi Kou *Greater Bay Biomedical Innocenter, Shenzhen Bay Laboratory, Shenzhen, China.ORCID 0000-0003-4662-3652
Chenbo Sun *Greater Bay Biomedical Innocenter, Shenzhen Bay Laboratory, Shenzhen, China.
Weitao ChenShenzhen Key Laboratory for Neuronal Structural Biology, Biomedical Research Institute, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
Hanyu GaoDepartment of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, China.
Fei SunGreater Bay Biomedical Innocenter, Shenzhen Bay Laboratory, Shenzhen, China.ORCID 0000-0002-3065-7471

Funding

Ministry of Science and Technology 2020YFA0908100Research Grants Council of Hong Kong SAR 16103421Research Grants Council of Hong Kong SAR C6001-23YResearch Grants Council of Hong Kong SAR RFS2324-6S05Research Grants Council of Hong Kong SAR T13-602/21-NResearch Institute of Tsinghua, Pearl River Delta RITPRD21EG01Shenzhen Bay Laboratory Startup Fund 21320061
6 · The paper itself

Abstract

Mirror-image proteins and nucleic acids exhibit remarkable biostability and bioorthogonality, offering a promising strategy to enhance the longevity of biological therapeutics. Here, we present a modular approach for constructing complex protein architectures that integrate both natural-chirality (L-) and mirror-image (D-) motifs. Key to this strategy is the development of D-SpyStapler-a chemically synthesized, chirally inverted ligase that enables the efficient conjugation of D-SpyTag and D-BDTag. By exploiting the achirality of glycine (Gly), we used L-sortase to covalently link D-peptides (e.g., SpyTag or BDTag, bearing an N-terminal poly-Gly motif) to L-proteins (e.g., GFP, VLP-forming Mi3, or antigens) containing a C-terminal LPXTG sorting signal. The resulting D-SpyTagged and D-BDTagged proteins were further assembled via D-SpyStapler. This method enabled the construction of chirally chimeric VLP vaccines displaying antigens derived from malaria parasites and coronaviruses in various forms-recombinant proteins or synthetic peptides-providing significant flexibility and modularity for vaccine design. The resulting chirally hybrid vaccines exhibited enhanced proteolytic resistance in vitro and elicited potent immune responses in vivo. This study provides a versatile platform for developing long-acting therapeutics and vaccines.

Indexed as

NanoparticlesVaccinesAnimalsMiceNanovaccinesNanovaccinesVaccinesChirally chimeric proteinMirror‐image proteinProtein nanoparticle vaccineProteolytic resistanceSpy chemistry

Identifiers

PMID40528680
PMCPMC12363629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.